AIIMS Bhubaneswar invites applications for Senior Resident posts; check aiimsbhubaneswar.nic.in

-

The All India Institute of Medical Sciences (AIIMS), Bhubaneswar is set to start the recruitment drive for Senior Resident posts. In total, there are 90 posts available.

The application window will open from 18 May and the last date to apply is 7 June. Once the process begins, aspirants can apply for the vacancies by visiting the official website aiimsbhubaneswar.nic.in. The recruitment will be valid for a maximum period of three years.

Once the registration window opens, aspirants can follow these simple steps to apply:

1. Visit aiimsbhubaneswar.nic.in

2. On the homepage, go to the ‘What’s New’ tab under ‘Recruitment’ section on 18 May

3. Register yourself

4. Login using credentials and Start filling the application form

5. Upload scanned copies of required documents

6. Upload scanned photograph and digital signature

7. Submit the form. Save a copy. If required, take a printout

Selection process:

1. A candidate can apply for more than one posts but on different application forms

2. Written tests will only be conducted when the applicants are more than three times the number of posts advertised

3. Merit list will be prepared on the basis of the written test and interview

4. The original certificates will be verified after the selection

Eligibility criteria:

1. A candidate should not be more than 45 years of age. There is a relaxation of 5 years for SC/ST candidates, 3 years for OBC applicants. For Persons with Disabilities (PWD), relaxation is 10 years for general category candidates, 13 years for OBC aspirants, and 15 years for people belonging to SC/ST category

2. He/She should have a postgraduate medical degree viz MD/MS/MDS/DM/M.Ch/DNB recognised by Medical Council of India

3. Those who have completed three years of residency scheme are not eligible to apply

4. For Senior Resident in the Department of Hospital Administration, the maximum age to apply is 40 years

For department-wise eligibility, refer to the official notification:



from Firstpost India Latest News https://ift.tt/3w8Bxfn
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more